medigraphic.com
SPANISH

Revista Médica MD

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 1

<< Back Next >>

Rev Med MD 2017; 8.9 (1)

Vascular malformations: report of a case with scleral involvement

Muñoz-Solórzano B, Bojórquez-Yáñez MI, Tornero-Jiménez A, Prado-Rivas JR, González-Pérez G
Full text How to cite this article

Language: Spanish
References: 11
Page: 99-102
PDF size: 758.80 Kb.


Key words:

complications, vascular malformation, treatment, orbital tumor.

ABSTRACT

Vascular anomalies are a frequent group of lesions in the pediatric age, they are classified into tumors and vascular malformations. Most of vascular tumors have a benign course and present spontaneous regression in the first years of life, unlike vascular malformations which characteristically occur since birth and do not present regression. It is necessary to make an adequate classification of the histopathological components and of the flow of the lesion, as this will determine the course and prognosis of the disease, as well as the need for treatment and its approach.
Vascular malformations locate in the orbital region, however, there are not many reported cases of scleral involvement. This type of injury has the potential to affect eye health and vision, resulting in a mass effect, proptosis, bleeding, restriction of eye movements and permanent visual disturbances. The diagnosis and treatment become a challenge that requires a multidisciplinary approach to establish the medical or surgical interventions. We present the case of a vascular malformation with both scleral and orbital involvement, its approach and management


REFERENCES

  1. Wassef M, Blei F, et al. Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics. 2015;136(1):1-14.

  2. 2.ISSVA

  3. 3.Forbess C, Fallon S, et al. Review Article Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment. Wileyonlinelibrary.com 2017.

  4. 4.Stacey A., Gemmete J, et al, Management of Orbital and Periocular Vascular Anomalies, Ophtal Plast Reconstr Surg 2015; 31:427-436.

  5. 5.Shields C, Alset A, et al. Conjunctival Tumors in 5002 Cases. Comparative Analysis of Benign versus Malignant Counterparts. Am J Ophthalmol. 2016.

  6. 6.Rootman J, Heran M, et al. Vascular Malformatios of the Orbit: Classification and the Role of Imaging in Diagnosis an Treatment Strategies, Ophtal Plast Reconstr Surg 2014; 30:91-104

  7. 7.Russin J, Rangel-Castila L, et al. Surgical management, outcomes, and recurrence rate of orbital lymphangiomas. Journal of Clinical Neuroscience 22(2015), 877-882.

  8. 8.Chandrakant K, Kalantzis G, et al. Sclerotherapy for Orbital Lymphangioma- Case Series and Literature Review. In vivo. 2017;31:263-266.

  9. 9.Chiramel G, Nidugala S, et al, Percutaneous Sclerotherapy of Congenital Slow Flow Vascular Malformations of the Orbit, Cardiovasc Intervent Radiol Cardiovasc Intervent Radiol(2014)

  10. 10.Heran F, Galatoire O., et al. Pathologie vasculaire orbito-palpebrale, Journal français d´ophtalmologie 2016;39:804-813.

  11. 11.Reem R, Golden R, Periocular Hemangiomas and Lymphangiomas, Pediatr Clin N Am 2014;61:541-553




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med MD. 2017;8.9